disopyramide has been researched along with Tachycardia, Paroxysmal in 50 studies
Disopyramide: A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties.
disopyramide : A monocarboxylic acid amide that is butanamide substituted by a diisopropylamino group at position 4, a phenyl group at position 2 and a pyridin-2-yl group at position 2. It is used as a anti-arrhythmia drug.
Tachycardia, Paroxysmal: Abnormally rapid heartbeats with sudden onset and cessation.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The purpose of this present study was to test whether P-SAECG mapping system would give any information on the efficacy of disopyramide on the prevention of paroxysmal atrial fibrillation (PAF)." | 7.70 | Dispersion of filtered P wave duration by P wave signal-averaged ECG mapping system: its usefulness for determining efficacy of disopyramide on paroxysmal atrial fibrillation. ( Hiraki, T; Ikeda, H; Imaizumi, T; Kubara, I; Ohga, M; Yoshida, T, 1999) |
| "Three cases are described with documented ventricular fibrillation shortly after the patients received disopyramide in moderate dosage." | 7.66 | Disopyramide-induced ventricular fibrillation. ( Gracey, JG; Knoch, HR; Martin, CE; Nicholson, WJ, 1979) |
| " The purpose of this present study was to test whether P-SAECG mapping system would give any information on the efficacy of disopyramide on the prevention of paroxysmal atrial fibrillation (PAF)." | 3.70 | Dispersion of filtered P wave duration by P wave signal-averaged ECG mapping system: its usefulness for determining efficacy of disopyramide on paroxysmal atrial fibrillation. ( Hiraki, T; Ikeda, H; Imaizumi, T; Kubara, I; Ohga, M; Yoshida, T, 1999) |
| "In this study, the safety and efficacy of long-term therapy with disopyramide phosphate were evaluated in 40 patients with documented, recurrent, symptomatic tachyarrhythmias." | 3.67 | Long-term therapy with disopyramide phosphate: side effects and effectiveness. ( Bauernfeind, RA; Bauman, JL; Gallastegui, J; Hoff, J; Strasberg, B; Swiryn, S; Welch, WJ, 1986) |
| ", verapamil, disopyramide, and procainamide, on paroxysmal supraventricular tachycardia (PSVT), atrial fibrillation (Af) and atrial flutter (AF) were evaluated electrophysiologically." | 3.66 | Electrophysiologic evaluation of antiarrhythmic drugs on supraventricular tachyarrhythmias. ( Hiejima, K; Satake, S; Suzuki, F; Takahashi, M, 1983) |
| "Three cases are described with documented ventricular fibrillation shortly after the patients received disopyramide in moderate dosage." | 3.66 | Disopyramide-induced ventricular fibrillation. ( Gracey, JG; Knoch, HR; Martin, CE; Nicholson, WJ, 1979) |
| "Disopyramide phosphate was administered intravenously to 57 patients with 60 episodes of arrhythmia (21 supraventricular and 39 ventricular) as a 2 mg/kg bolus." | 3.65 | The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate. ( Deano, DA; Ehsani, AI; Mautner, RK; Rosen, KM; Sherman, RH; Wu, D, 1977) |
| "Disopyramide was given intravenously to all patients during tachycardia." | 2.65 | Effects of intravenous and oral disopyramide on paroxysmal atrioventricular nodal tachycardia. ( Brugada, P; Wellens, HJ, 1984) |
| " The dosage of disopyramide phosphate should be sufficiently high and must be individualized." | 2.64 | [Clinical studies of the antiarrhythmic efficacy of disopyramide phosphate (Norpace) (author's transl)]. ( Smith, WS, 1978) |
| "Disopyramide (1,7 mg/kg) was administered in 10 patients." | 2.64 | [Electrophysiological effects of the antiarrhythmia agents disopyramide and propafenone on human heart conduction system]. ( Both, A; Breithardt, G; Seipel, L, 1975) |
| " Propafenone controlled dysrhythmia very well in 4 out of the ten patients, and satisfactorily in another one at a dosage ranging from 450 to 900 mg/day in 3 or 4 divided doses; this result was documented using continuous 24 hr." | 1.28 | [Anti-arrhythmia efficacy of propafenone per os in the prevention of paroxysmal supraventricular arrhythmia resistant to class Ia agents]. ( Amiel, A; Boutaud, P; Ciber, M; Demange, J; Guillem, JP; Herpin, D; Maarek-Charbit, M, 1989) |
| "In the manifest WPW syndrome, disopyramide or aprindine was indicated especially for patients with the accessory pathways of the short antegrade refractory period, because these drugs lengthened the refractory period of the accessory pathways." | 1.27 | Usefulness of invasive and non-invasive electrophysiologic studies in the selection of antiarrhythmic drugs for the patients with paroxysmal supraventricular tachyarrhythmia. ( Hiejima, K; Hirao, K; Kubo, I; Moroi, Y; Satake, S; Suzuki, F, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 43 (86.00) | 18.7374 |
| 1990's | 7 (14.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pernot, C | 1 |
| Jacob, F | 1 |
| Hoeffel, JC | 1 |
| Theisen, K | 2 |
| Jahrmärker, H | 1 |
| Brugada, P | 1 |
| Wellens, HJ | 1 |
| Komatsu, C | 1 |
| Ishinaga, T | 1 |
| Tateishi, O | 1 |
| Tokuhisa, Y | 1 |
| Hara, M | 1 |
| Sanada, T | 1 |
| Kanae, K | 1 |
| Satoh, Y | 1 |
| Yoshimura, S | 1 |
| Grosu, AA | 2 |
| Lewis, DO | 1 |
| Yanaga, T | 1 |
| Ichimaru, Y | 1 |
| Ueno, T | 1 |
| Hata, Y | 1 |
| Okamoto, K | 1 |
| Kodama, Y | 1 |
| Otsuka, K | 1 |
| Hiejima, K | 2 |
| Suzuki, F | 3 |
| Takahashi, M | 1 |
| Satake, S | 2 |
| Sethi, KK | 1 |
| Jaishankar, S | 1 |
| Khalilullah, M | 1 |
| Gupta, MP | 1 |
| Bauernfeind, RA | 5 |
| Swiryn, S | 4 |
| Petropoulos, AT | 1 |
| Coelho, A | 1 |
| Gallastegui, J | 2 |
| Rosen, KM | 6 |
| Duffy, CE | 1 |
| Strasberg, B | 4 |
| Palileo, E | 3 |
| Swiryn, SP | 1 |
| Scagliotti, D | 1 |
| Malakhov, VI | 1 |
| Smetnev, AS | 1 |
| Katoh, T | 1 |
| Sasaki, Y | 1 |
| Tsuda, T | 1 |
| Wyndham, CR | 2 |
| Dhingra, RC | 1 |
| Keren, A | 1 |
| Tzivoni, D | 1 |
| Gavish, D | 1 |
| Levi, J | 1 |
| Gottlieb, S | 1 |
| Benhorin, J | 1 |
| Stern, S | 1 |
| Satoh, M | 1 |
| Sada, T | 1 |
| Kuan-Min, S | 1 |
| Kira, Y | 1 |
| Sekine, I | 1 |
| Okabe, F | 1 |
| Ueda, A | 1 |
| Ito, T | 1 |
| Matsumoto, S | 1 |
| Kimura, E | 1 |
| Mashima, S | 1 |
| Tanaka, T | 1 |
| Boudonas, G | 1 |
| Lefkos, N | 1 |
| Efthymiadis, AP | 1 |
| Styliadis, IG | 1 |
| Tsapas, G | 1 |
| Fujiki, A | 1 |
| Yoshida, S | 1 |
| Tani, M | 1 |
| Inoue, H | 1 |
| Manz, M | 1 |
| Lüderitz, B | 1 |
| van den Berg, MP | 1 |
| Haaksma, J | 1 |
| Brouwer, J | 1 |
| Crijns, HJ | 1 |
| Lie, KI | 1 |
| Kubara, I | 1 |
| Ikeda, H | 1 |
| Hiraki, T | 1 |
| Yoshida, T | 1 |
| Ohga, M | 1 |
| Imaizumi, T | 1 |
| Donaldson, RM | 1 |
| Falk, RH | 1 |
| Nisbet, PA | 1 |
| Gray, TJ | 1 |
| Perroni, GB | 1 |
| Briguglio, FS | 1 |
| Oddo, A | 1 |
| Trovato, G | 1 |
| Camm, J | 2 |
| Ward, D | 2 |
| Washington, HG | 1 |
| Spurrell, RA | 2 |
| Smith, WS | 1 |
| Millar-Craig, MW | 1 |
| Raftery, EB | 1 |
| Nicholson, WJ | 1 |
| Martin, CE | 1 |
| Gracey, JG | 1 |
| Knoch, HR | 1 |
| Shaxted, EJ | 1 |
| Milton, PJ | 1 |
| Rouhi, A | 1 |
| Penth, B | 1 |
| Adams, HJ | 1 |
| Deano, DA | 1 |
| Wu, D | 2 |
| Mautner, RK | 1 |
| Sherman, RH | 1 |
| Ehsani, AI | 1 |
| Amat-y-Leon, F | 1 |
| Simpson, RJ | 1 |
| Latif, P | 1 |
| Denes, P | 1 |
| Caracta, A | 1 |
| Seipel, L | 1 |
| Breithardt, G | 1 |
| Both, A | 1 |
| Perederiĭ, VG | 1 |
| Nikitin, AV | 1 |
| Zemskov, AM | 1 |
| Gusmanov, VA | 1 |
| Grishkin, IuN | 1 |
| Shpektor, AV | 2 |
| Gorshkov, VA | 1 |
| Mamaev, VI | 2 |
| Orlov, VN | 1 |
| Susliak, NN | 1 |
| Boutaud, P | 1 |
| Guillem, JP | 1 |
| Maarek-Charbit, M | 1 |
| Amiel, A | 1 |
| Ciber, M | 1 |
| Herpin, D | 1 |
| Demange, J | 1 |
| Bauman, JL | 1 |
| Hoff, J | 1 |
| Welch, WJ | 1 |
| Gushchin, IV | 1 |
| Gimrikh, EO | 1 |
| Volkova, TG | 1 |
| Chernov, VI | 1 |
| Kasanuki, H | 1 |
| Onishi, S | 1 |
| Hirosawa, K | 1 |
| Komarov, FI | 1 |
| Ol'binskaia, LI | 1 |
| Kuz'mina, MM | 1 |
| Moroi, Y | 1 |
| Hirao, K | 1 |
| Kubo, I | 1 |
| Bleifer, DJ | 1 |
| Hansmann, DR | 1 |
| Bleifer, SB | 1 |
| Sheppard, JS | 1 |
| Karpman, HL | 1 |
| Dzieglielewski, T | 1 |
| Wachowiak, A | 1 |
3 reviews available for disopyramide and Tachycardia, Paroxysmal
| Article | Year |
|---|---|
[Idiopathic dilatation of the right atrium manifested in infancy by arrhythmia].
Topics: Acetyldigoxins; Angiocardiography; Anti-Arrhythmia Agents; Cardiac Catheterization; Child; Dilatatio | 1976 |
[Medical treatment of extrasystole and tachycardia (author's transl)].
Topics: Action Potentials; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Bretylium Compounds; Calcium; Cardi | 1980 |
Supraventricular tachycardia and pre-excitation syndromes: pharmacological therapy.
Topics: Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Disopyramide; Fle | 1993 |
7 trials available for disopyramide and Tachycardia, Paroxysmal
| Article | Year |
|---|---|
Effects of intravenous and oral disopyramide on paroxysmal atrioventricular nodal tachycardia.
Topics: Administration, Oral; Adult; Aged; Atrioventricular Node; Clinical Trials as Topic; Disopyramide; El | 1984 |
Intravenous administration of diltiazem in the treatment of supraventricular tachyarrhythmias.
Topics: Adult; Atrial Fibrillation; Atrial Flutter; Blood Pressure; Diltiazem; Disopyramide; Electrocardiogr | 1995 |
[Clinical studies of the antiarrhythmic efficacy of disopyramide phosphate (Norpace) (author's transl)].
Topics: Administration, Oral; Cardiac Complexes, Premature; Clinical Trials as Topic; Disopyramide; Double-B | 1978 |
A double-blind trial of disopyramide, procaineamide and digoxin in paroxysmal suptraventricular tachycardia.
Topics: Adult; Aged; Clinical Trials as Topic; Digoxin; Disopyramide; Double-Blind Method; Female; Humans; M | 1979 |
[Electrophysiological effects of the antiarrhythmia agents disopyramide and propafenone on human heart conduction system].
Topics: Adult; Anti-Arrhythmia Agents; Bundle of His; Disopyramide; Electric Stimulation; Electrocardiograph | 1975 |
[Comparative effectiveness of neogilurytmal, novocainamide, etmozin, disopyramide and ethacizine in ventricular arrhythmias].
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Clinical Trials as To | 1987 |
[Comparative effectiveness of Na+ channel blockers in ventricular disorders of cardiac rhythm].
Topics: Adult; Aged; Calcium Channel Blockers; Cardiac Complexes, Premature; Clinical Trials as Topic; Disop | 1989 |
40 other studies available for disopyramide and Tachycardia, Paroxysmal
| Article | Year |
|---|---|
[Pharmacotherapy of paroxysmal tachycardia].
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Atrial Flutter; Digitalis Glycosides; Disopyramide | 1983 |
[Effects of intravenous disopyramide on induction and termination of paroxysmal supraventricular tachycardia via an accessory pathway].
Topics: Adolescent; Adult; Aged; Cardiac Pacing, Artificial; Disopyramide; Electrophysiology; Female; Heart | 1984 |
[Effectiveness and mechanism of the anti-arrhythmic action of ritmilen in patients with paroxysms of atrioventricular node reciprocal tachycardia].
Topics: Adult; Anti-Arrhythmia Agents; Disopyramide; Drug Evaluation; Female; Humans; Male; Middle Aged; Tac | 1984 |
Serendipitous relief with disopyramide of phobia for flying.
Topics: Adult; Disopyramide; Female; Humans; Phobic Disorders; Tachycardia, Paroxysmal | 1983 |
The usefulness of Holter monitoring in the evaluation of antiarrhythmic drug efficacy for tachycardia.
Topics: Adult; Aged; Angina Pectoris, Variant; Anti-Arrhythmia Agents; Diltiazem; Disopyramide; Female; Hear | 1983 |
Electrophysiologic evaluation of antiarrhythmic drugs on supraventricular tachyarrhythmias.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Atrioventricular Node; Disopyramide; El | 1983 |
Selective blockade of retrograde fast pathway by intravenous disopyramide in paroxysmal supraventricular tachycardia mediated by dual atrioventricular nodal pathways.
Topics: Adult; Atrioventricular Node; Disopyramide; Electrocardiography; Female; Heart Conduction System; Hu | 1983 |
Concordance and discordance of drug responses in atrioventricular reentrant tachycardia.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Atrioventricular Node; Cardiac Pacing, Artificial; | 1983 |
Inducible sustained ventricular tachycardia refractory to individual class I drugs: effect of adding a second class I drug.
Topics: Aged; Anti-Arrhythmia Agents; Disopyramide; Drug Therapy, Combination; Electric Stimulation; Electro | 1983 |
Electrophysiologic drug testing in prophylaxis of sporadic paroxysmal atrial fibrillation: technique, application, and efficacy in severely symptomatic preexcitation patients.
Topics: Administration, Oral; Adolescent; Adult; Aprindine; Atrial Fibrillation; Cardiac Pacing, Artificial; | 1982 |
[Electrophysiological action of disopyramide].
Topics: Adolescent; Adult; Atrial Fibrillation; Cardiac Catheterization; Disopyramide; Drug Evaluation; Elec | 1982 |
[Effects of disopyramide phosphate in repetitive paroxysmal ventricular tachycardia].
Topics: Disopyramide; Female; Humans; Pyridines; Tachycardia, Paroxysmal | 1982 |
Effects of oral disopyramide phosphate on induction of paroxysmal supraventricular tachycardia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Atrioventricular Node; Disopyramide; Female; Heart Co | 1981 |
Etiology, warning signs and therapy of torsade de pointes. A study of 10 patients.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Disopyramide; Electrocardiography; Female; Heart Ve | 1981 |
[Antiarrhythmic actions of disopyramide phosphate in patients with paroxysmal supraventricular tachycardia (author's transl)].
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Disopyramide; Female; Humans; Male; Middle Aged; Myocardi | 1981 |
Clinical evaluation of antiarrhythmic effects of disopyramide by multiclinical controlled double-blind methods.
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Disopyramide; Double-Blind Method; Drug Evaluation; Human | 1980 |
Efficacy of class Ia antiarrhythmic drugs in converting atrial fibrillation unassociated with organic heart disease and their relation to atrial electrophysiologic characteristics.
Topics: Adult; Aged; Atrial Fibrillation; Cardiac Pacing, Artificial; Disopyramide; Electrophysiology; Femal | 1994 |
Analysis of heart rate variability in a patient with paroxysmal atrial fibrillation.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Disopyramide; Electrocardiography; Heart Rate; Humans; | 1995 |
Dispersion of filtered P wave duration by P wave signal-averaged ECG mapping system: its usefulness for determining efficacy of disopyramide on paroxysmal atrial fibrillation.
Topics: Administration, Oral; Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Body Surface Potenti | 1999 |
The treatment of supraventricular arrhythmias.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Arrhyt | 1979 |
Mental distress in patient on disopyramide.
Topics: Disopyramide; Female; Humans; Middle Aged; Psychoses, Substance-Induced; Pyridines; Tachycardia, Par | 1977 |
[Data on disopyridamide therapy of some arrhythmias].
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Complexes, Premature; Disopyramid | 1977 |
Intravenous disopyramide phosphate and ventricular overdrive pacing in the termination of paroxysmal ventricular tachycardia.
Topics: Adult; Cardiac Pacing, Artificial; Disopyramide; Electrocardiography; Female; Heart Ventricles; Huma | 1979 |
Disopyramide-induced ventricular fibrillation.
Topics: Administration, Oral; Aged; Arrhythmias, Cardiac; Disopyramide; Electrocardiography; Female; Heart B | 1979 |
Disopyramide in pregnancy: a case report.
Topics: Adult; Arrhythmias, Cardiac; Disopyramide; Electrocardiography; Female; Heart Rate; Humans; Pregnanc | 1979 |
[Prevention and therapy of supraventricular paroxysmal tachycardia in ambulatory patients. Results of a multicentric study using disopyramide].
Topics: Adult; Aged; Ambulatory Care; Disopyramide; Female; Germany, West; Humans; Male; Middle Aged; Pyridi | 1979 |
The effect of intravenous disopyramide phosphate on recurrent paroxysmal tachycardias.
Topics: Atrial Fibrillation; Atrial Flutter; Blood Pressure; Disopyramide; Electrocardiography; Humans; Infu | 1979 |
The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate.
Topics: Administration, Oral; Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Disopy | 1977 |
Electrophysiological studies with multiple drugs in patients with atrioventricular re-entrant tachycardias utilizing an extranodal pathway.
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Aprindine; Atrioventricular Node; Bundle of His; Cardiac | 1977 |
The electrophysiology of Norpace (Part III).
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrioventricular Node; Bundle of His; Chronaxy; Disopy | 1975 |
[The possible significance of immunological disorders in the pathogenesis of paroxysmal supraventricular tachycardia in patients with the Wolff-Parkinson-White syndrome].
Topics: Adjuvants, Immunologic; Adult; Disease Susceptibility; Disopyramide; Drug Therapy, Combination; Fema | 1992 |
[Effect of ritmilen on myocardial refractility and cardiac impulse conduction in patients with paroxysmal tachycardia].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Disopyramide; Heart Atria; Heart Conduction System; Heart Ventr | 1991 |
[Anti-arrhythmia efficacy of propafenone per os in the prevention of paroxysmal supraventricular arrhythmia resistant to class Ia agents].
Topics: Administration, Oral; Aged; Disopyramide; Drug Evaluation; Drug Resistance; Female; Humans; Male; Mi | 1989 |
Long-term therapy with disopyramide phosphate: side effects and effectiveness.
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Disopyramide; Drug Tolerance; El | 1986 |
[Combined effects of cordarone and ritmilen on the contractile function of the myocardium after intravenous and oral administration of loading doses].
Topics: Administration, Oral; Adult; Aged; Amiodarone; Depression, Chemical; Disopyramide; Drug Synergism; D | 1988 |
The usefulness of electrophysiological-pharmacologic studies in the long-term therapy of paroxysmal tachycardias.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Cardiomyopathies; Chromatogra | 1985 |
[Echocardiographic indices of cardiac function and systemic hemodynamics in patients with cardiac fibrillation paroxysms and their dynamics as affected by disopyramide phosphate].
Topics: Disopyramide; Echocardiography; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contract | 1985 |
Usefulness of invasive and non-invasive electrophysiologic studies in the selection of antiarrhythmic drugs for the patients with paroxysmal supraventricular tachyarrhythmia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Bundle of His; Disopyramide; | 1985 |
Continuous ECG (Holter) recordings in the evaluation of antiarrhythmic drugs.
Topics: Arrhythmias, Cardiac; Cardiac Complexes, Premature; Disopyramide; Drug Evaluation; Electrocardiograp | 1974 |
[Clinical evaluation of Rhytmodan in heart rhythm disorders].
Topics: Administration, Oral; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Drug | 1973 |